Article Versions Notes

Guedes RA, Grilo JH, Carvalho AN, Fernandes PMP, Ressurreição AS, Brito V, Santos AO, Silvestre S, Gallerani E, Gama MJ, et al. New Scaffolds of Proteasome Inhibitors: Boosting Anticancer Potential by Exploiting the Synergy of In Silico and In Vitro Methodologies. Pharmaceuticals. 2023; 16(8):1096. https://doi.org/10.3390/ph16081096

Guedes, Romina A., Jorge H. Grilo, Andreia N. Carvalho, Pedro M. P. Fernandes, Ana S. Ressurreição, Vanessa Brito, Adriana O. Santos, Samuel Silvestre, Eleonora Gallerani, Maria João Gama, and et al. 2023. "New Scaffolds of Proteasome Inhibitors: Boosting Anticancer Potential by Exploiting the Synergy of In Silico and In Vitro Methodologies" Pharmaceuticals 16, no. 8: 1096. https://doi.org/10.3390/ph16081096

Guedes, R. A., Grilo, J. H., Carvalho, A. N., Fernandes, P. M. P., Ressurreição, A. S., Brito, V., Santos, A. O., Silvestre, S., Gallerani, E., Gama, M. J., Gavioli, R., Salvador, J. A. R., & Guedes, R. C. (2023). New Scaffolds of Proteasome Inhibitors: Boosting Anticancer Potential by Exploiting the Synergy of In Silico and In Vitro Methodologies. Pharmaceuticals, 16(8), 1096. https://doi.org/10.3390/ph16081096